このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

正規化された日常診療としての母親の周産期精神障害の普遍的予防のための実現可能性調査およびパイロットハイブリッド効果実施試験(e-周産期パイロット)

2026年9月18日 更新者:Emma Motrico、University of Seville

母親の周産期精神障害の普遍的予防と正規化された日常診療としてのその実施(e-周産期):パイロットランダム化対照試験(WP2)

This study is part of the e-Perinatal project, funded by the European Research Council. This research project will follow the first three phases recommended by the Medical Research Council (MRC) framework for the development and evaluation of complex interventions (Skivington et al., 2021).

The primary aim is to evaluate the feasibility and acceptability of implementing an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. Using a pilot, two-arm, cluster-randomized hybrid type 1 clinical trial, the study will assess key implementation outcomes and preliminary effectiveness indicators. The findings will inform the design of a future large clinical trial, intending to evaluate the effectiveness, cost-effectiveness, and implementation of the intervention as part of maternal care.

調査の概要

状態

完了

条件

介入・治療

詳細な説明

This pilot clinical study investigates the feasibility, acceptability, and preliminary implementation and effectiveness of the e-Perinatal app, an innovative, personalized mobile health (mHealth) intervention designed for the universal prevention of perinatal mental disorders. The study will be conducted as a two-arm, cluster-randomized, hybrid type 1 trial within routine maternal care settings in primary healthcare centers in Andalusia, Spain. Participants will include pregnant and postpartum women (up to five months postpartum) and their partners. Primary healthcare centers will be randomized to either the intervention or control arm.

The primary objective is to evaluate the feasibility of integrating the e-Perinatal app into routine maternal care. Secondary objectives include assessing the acceptability of the intervention among women, partners, and healthcare professionals and exploring preliminary effectiveness outcomes, such as the incidence of perinatal depression and anxiety in women, changes in depressive and anxiety symptoms in both women and their partners, and potential impacts on infant health and development.

The study hypothesizes that the e-Perinatal intervention will be feasible and acceptable for pregnant and postpartum women, their partners, and healthcare professionals involved in routine maternal care.

Participants will be recruited from primary healthcare centres and allocated by cluster randomization to either the intervention group, which will receive the e-Perinatal app along with standard maternal care, or the control group, which will receive standard maternal care and monthly psychoeducational emails.

研究の種類

介入

入学 (実際)

96

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Seville
      • Mairena del Aljarafe、Seville、スペイン、41927
        • Primary Health Care Center Mairena del Aljarafe - Ciudad Expo

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion criteria for mothers:

  • Must receive an invitation to participate from a healthcare professional at one of the participating primary healthcare centers
  • Must be pregnant for at least 16 weeks or have given birth within the last 5 months at the time of enrollment
  • Must be at least 18 years old
  • Must have access to a mobile phone and internet connection
  • Must be able to read, write, and understand Spanish
  • Must have a personal email account

Inclusion criteria for partners (or significant others):

  • Must receive an invitation to participate from a woman already enrolled in the study
  • Must be at least 18 years old
  • Must have access to a mobile phone and internet connection
  • Must be able to read, write, and understand Spanish
  • Must have a personal email account

Exclusion criteria for mothers:

  • Meet diagnostic criteria for anxiety or depression, as determined by a structured clinical interview
  • Be on a waiting list or currently receiving psychological or pharmacological treatment for any mental health or substance use condition

Exclusion criteria for partners (or significant others):

  • There are no exclusion criteria for partners

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:介入群

The e-Perinatal intervention combines a personalized mobile health (mHealth) app with targeted training for healthcare professionals to support perinatal mental health within routine maternal care. Participants allocated to the intervention arm will use the app for a period of two months. The app offers psychoeducational content, video-guided physical activities, mindfulness exercises, mood-tracking tools, personalized recommendations through a rule-based algorithm, and social-community features. Healthcare professionals assigned to the intervention arm receive specialized training to integrate the app into their daily practice, enhancing their ability to promote and support mental health during the perinatal period.

アクティブコンパレータ:対照群

Standard maternal care as routinely provided by the Andalusian public healthcare system (Spain). This includes scheduled visits with midwives, nurses, and pediatrician for maternal and infant health monitoring, as well as access to childbirth education programmes. Participants also receive monthly psychoeducational emails (two months) containing general information on perinatal mental health, pregnancy, and infant development. Healthcare professionals in this arm do not receive specialized training in perinatal mental health or in the use of digital interventions, and participants do not have access to the e-Perinatal app.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Feasibility of the intervention
時間枠:Measured at baseline and postintervention (2 months after baseline)

Calculation of participation rate, recruitment rate, and retention rate (follow-up rate) at all assessment points. Assessment method: Registration and follow-up records.

Measured at baseline and postintervention (2 months after baseline)
Early acceptability
時間枠:Measured at enrollment

Number of eligible women and partners who agree to participate. Assessment method: Consent forms.

Measured at enrollment
Final acceptability
時間枠:Measured at postintervention (2 months after baseline)

Evaluation of how appropriate, satisfactory, and feasible the intervention is after its implementation. Assessment method: Surveys and semi-structured interviews based on the Normalization Process Theory.

Measured at postintervention (2 months after baseline)

二次結果の測定

結果測定
メジャーの説明
時間枠
Adoption
時間枠:Measured before recruitment

Proportion of Primary Health Care (PHC) professionals who express their willingness to participate in the study among the total of potential professionals prior to the start of the intervention. Assessment method: Registration records.

Measured before recruitment
Fidelity
時間枠:Measured at postintervention (2 months after baseline)

Measures adherence to the study protocol by PHC professionals. Assessment method: Surveys.

Measured at postintervention (2 months after baseline)
Early appropriateness
時間枠:Measured at enrollment

Number of eligible women and number of partners invited to participate by women. Assessment method: Consent forms and recruitment records.

Measured at enrollment
Final appropriateness
時間枠:Measured at postintervention (2 months after baseline)

Suitability and relevance of the intervention for the target population and context. Assessment method: Semi-structured interviews based on the Normalization Process Theory.

Measured at postintervention (2 months after baseline)
Cumulative incidence of maternal perinatal depression and maternal perinatal anxiety
時間枠:Measured at enrollment and postintervention (2 months after baseline)

Measurement of the incidence of maternal perinatal depression and anxiety. Assessment method: The Mini International Neuropsychiatric Interview (MINI).

Measured at enrollment and postintervention (2 months after baseline)
Depressive symptoms
時間枠:Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in depressive symptoms. Assessment method: The Edinburgh Postnatal Depression Scale (EPDS), a 10-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe depressive symptoms.

Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)
Anxiety symptoms
時間枠:Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in anxiety symptoms. Assessment method: The General Anxiety Questionnaire (GAD-7), a 7-item self-report measure. Each item is scored from 0 to 3, with higher scores indicating more severe anxiety symptoms.

Measured at enrollment, postintervention (2 months after baseline), and follow-up (1 month after postintervention)
Postnatal post-traumatic stress
時間枠:Measured at baseline

Presence of post-traumatic stress symptoms and clinical disorder in women or their partners after childbirth. Assessment method: Assessed using City Birth Trauma Scale (City-BiTS), a 31-item self-report measure. Some items are scored from 0 to 3 and others from 0 to 2, with higher scores indicating greater severity of postnatal post-traumatic stress.

Measured at baseline
Well-being
時間枠:Measured at baseline, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

Changes in subjective well-being. Assessment method: The Well-Being Index (WHO-5), a 5-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating better subjective well-being.

Measured at baseline, postintervention (2 months after baseline), and follow-up (1 month after postintervention)

その他の成果指標

結果測定
メジャーの説明
時間枠
Organizational readiness for implementing change
時間枠:Measured before recruitment

Organization's readiness for implementing changes in usual care. Assessment method: The Organizational Readiness Implementing Change (ORIC), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating greater readiness for implementing change.

Measured before recruitment
App quality
時間枠:Measured at postintervention (2 months after baseline)

Objective and subjective quality, and the perceived impact of the application. Assessment method: The User Version of the Mobile Application Rating Scale (u-MARS), a 26-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better app quality.

Measured at postintervention (2 months after baseline)
Implementation process
時間枠:Measured at postintervention (2 months after baseline)

App implementation process from the perspective of healthcare professionals involved in implementing complex interventions. Assessment method: The Normalization Measure Development Questionnaire (NoMAD), a 20-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating more effective implementation processes.

Measured at postintervention (2 months after baseline)
Barriers and facilitators
時間枠:Measured at postintervention (2 months after baseline)

Identifies barriers and facilitators impacting the integration of the intervention into routine healthcare, drawing from the experiences of users and healthcare professionals. Assessment method: Semi-structured interviews following the Normalization Process Theory (NPT) framework

Measured at postintervention (2 months after baseline)
PHC characteristics
時間枠:Measured before recruitment

Size of the population where the PHC is located and number of PHC professionals. Assessment method: Questionnaire developed by the research team

Measured before recruitment
Reasons for dropout
時間枠:Measured at postintervention (2 months after baseline)

Number and reasons (e.g., experienced miscarriage or stillbirth, lack of engagement with the app) for dropout among women and their partners. Assessment method: Records and semi structured interviews.

Measured at postintervention (2 months after baseline)
Antenatal and postnatal risks
時間枠:Measured at baseline

Measures both antenatal and postnatal risk factors. Assessment method: The Antenatal Risk Questionnaire (ANRQ-R), a 11-item self-report measure. Some items are scored from 1 to 5 and others are scored on categorical scale, with higher scores indicating greater risk.

Measured at baseline
Maternal antenatal attachment
時間枠:Measured at baseline

Measures the level of maternal antenatal attachment to the baby. Assessment method: The Maternal Antenatal Attachment Scale (MAAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal antenatal attachment.

Measured at baseline
Paternal antenatal attachment
時間枠:Measured at baseline

Measures the level of paternal antenatal attachment to the baby. Assessment method: The Paternal Antenatal Attachment Scale (PAAS), a 16-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal antenatal attachment.

Measured at baseline
Maternal postnatal attachment
時間枠:Measured at baseline

Measures the level of maternal postnatal attachment to the baby. Assessment method: The Maternal Postnatal Attachment Scale (MPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger maternal postnatal attachment.

Measured at baseline
Paternal postnatal attachment
時間枠:Measured at baseline

Measures the level of postnatal attachment to the baby in both mothers and fathers. Assessment method: The Paternal Postnatal Attachment Scale (PPAS), a 19-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating stronger paternal postnatal attachment.

Measured at baseline
Infant temperament
時間枠:Measured at baseline

Measures various aspect of infant temperament. Assessment method: The Infant Behavior Questionnaire-Revised Short Form (IBQ-R SF), a 37-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.

Measured at baseline
Coparenting dynamics
時間枠:Measured at baseline

Measures the dynamics of coparenting relationships. Assessment method: The Coparenting Relationship Scale (CRS), a 14-item self-report measure. Each item is scored from 0 to 6, with higher scores indicating more positive coparenting dynamics.

Measured at baseline
Parental role perception
時間枠:Measured at baseline

Measures parents' perception of their competence in the parental role. Assessment method: The Parental Sense of Competence scale (PSOC), a 21-item self-report measure. Each item is scored from 1 to 6, with higher scores indicating a stronger sense of parental competence.

Measured at baseline
Infant development
時間枠:Measured at baseline

Measures various developmental milestones in infants.

Measured at baseline
Partnership quality
時間枠:Measured at baseline

Measures the quality of the marital or partnership relationship. Assessment method: The Quality of Marriage Index (QMI), a 6-item self-report measure. Some items are scored from 1 to 7 and others from 1 to 10, with higher scores indicating better relationship quality.

Measured at baseline
Sleep quality
時間枠:Measured at baseline

Measures the quality of sleep among participants. Assessment method: The Pittsburgh Sleep Quality Index (PSQI), a 19-item self-report measure. Some items are scored from 0 to 3 and some on a categorical scale, with higher scores indicating poorer sleep quality.

Measured at baseline
Life quality
時間枠:Measured at baseline

Measures the overall quality of life. Assessment method: The European Quality of Life-5 Dimensions-5 Levels (EuroQol-5D-5L), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating worse quality of life.

Measured at baseline
Maternal physical activity levels
時間枠:Measured at baseline

Measures physical activity levels in pregnant women and mothers. Assessment method: The Pregnancy Physical Activity Questionnaire (PPAQ), a 33-item self-report measure. Each item is scored from 0 to 5, with higher scores indicating higher levels of physical activity.

Measured at baseline
Paternal physical activity levels
時間枠:Measured at baseline

Measures physical activity levels in fathers. Assessment method: The International Physical Activity Questionnaire (IPAQ), a 7-item self-report measure. Each item is scored on a categorical scale, with higher scores indicating higher levels of physical activity.

Measured at baseline
Physical condition
時間枠:Measured at baseline

Measures overall physical condition and the main components (i.e., cardiorespiratory fitness, muscular strength, speed-agility, and flexibility) in pregnant women and mothers. Assessment method: The International FItness Scale (IFIS), a 5-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating better physical condition.

Measured at baseline
Mood state
時間枠:Measured at baseline

Measures positive and negative affect states. Assessment method: The Positive and Negative Affect Schedule (PANAS), a 20-item self-report measure. Each item is scored from 1 to 7, with higher scores indicating a higher frequency of the specified temperament behavior.

Measured at baseline
Basic psychological needs
時間枠:Measured at baseline

Measures the satisfaction and frustration of basic psychological needs. Assessment method: The Basic Psychological Need Satisfaction and Frustration Scale - Short Form (BPNSFS), a 12-item self-report measure. Each item is scored from 1 to 5, with higher scores indicating a higher need satisfaction (i.e., need satisfaction subscale) or a higher need frustration (i.e., need frustration subscale).

Measured at baseline
Economic data
時間枠:Measured at postintervention (2 months after baseline)

Measures healthcare service utilization and sick leave days over the previous year among participating women.

Assessment method: a post hoc semi-structured interview that collects information on emergency visits, hospital admissions, primary care visits (e.g., nurse, midwife, social worker), secondary care visits, and consultations with specialists.

Measured at postintervention (2 months after baseline)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

協力者

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

便利なリンク

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年5月2日

一次修了 (実際)

2025年11月11日

研究の完了 (実際)

2026年1月31日

試験登録日

最初に提出

2024年10月8日

QC基準を満たした最初の提出物

2024年10月11日

最初の投稿 (実際)

2024年10月15日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月23日

QC基準を満たした最後の更新が送信されました

2026年9月18日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • SICEIA-2024-001659
  • 101042139 (その他の助成金/資金番号:European Research Council (ERC))

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。